Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7JYR

hALK in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl-1H-pyrazol-3-yl)-4-(trifluoromethyl)phenoxy]cyclopropyl]methanamine

Summary for 7JYR
Entry DOI10.2210/pdb7jyr/pdb
Related7JY4
DescriptorALK tyrosine kinase receptor, 4-{[(1R,2R)-2-(2,4-difluorophenyl)cyclopropyl]oxy}-3-(5-methyl-1H-pyrazol-3-yl)benzonitrile, 1,2-ETHANEDIOL, ... (4 entities in total)
Functional Keywordsalk tyrosine kinase receptor, inhibitor, complex, kinase, sbdd, transferase-inhibitor complex, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight36520.86
Authors
McGrath, A.P.,Zou, H.,Lane, W.,Saikatendu, K. (deposition date: 2020-08-31, release date: 2021-01-20, Last modification date: 2023-10-18)
Primary citationFujimori, I.,Wakabayashi, T.,Murakami, M.,Okabe, A.,Ishii, T.,McGrath, A.,Zou, H.,Saikatendu, K.S.,Imoto, H.
Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design.
Acs Omega, 5:31984-32001, 2020
Cited by
PubMed: 33344853
DOI: 10.1021/acsomega.0c04900
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.32 Å)
Structure validation

221051

数据于2024-06-12公开中

PDB statisticsPDBj update infoContact PDBjnumon